-
Posted by
Two Blokes Jul 1 -
Filed in
Stock
-
5 views
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of IGM Biosciences, Inc. (NASDAQ: IGMS) to Concentra Biosciences, LLC is fair to IGM shareholders. Under the terms of the proposed transaction, IGM shareholders would receive $1.247 in cash per share, plus one non-tradeable contingent value right, representing the right to receive additional proceeds under certain circumstances and conditions. Halper Sadeh encourages IGM shareholders to c.
